A 52-year-old male smoker with a 30-year history of cigarette use presents with persistent cough and hemoptysis. Chest X-ray shows a mass in the left lower lobe. Bronchoscopy reveals a reddish, friable lesion in the left main bronchus. The bronchial mucosa appears abnormal with loss of normal ciliated columnar epithelium. Which investigation is most appropriate to confirm the diagnosis of squamous metaplasia with dysplasia?

Explanation

## Diagnostic Approach to Metaplasia and Dysplasia **Key Point:** Histopathology is the gold standard for confirming metaplasia and dysplasia. Bronchial brush biopsy allows direct tissue sampling from the lesion under visualization, enabling microscopic assessment of epithelial changes. ### Why Bronchial Brush Biopsy is Correct 1. **Direct tissue acquisition** — Allows visualization of the abnormal mucosa during bronchoscopy and simultaneous sampling 2. **Histological confirmation** — Demonstrates: - Replacement of normal ciliated columnar epithelium (metaplasia) - Nuclear enlargement, hyperchromasia, increased N:C ratio (dysplasia) - Preserved basement membrane (distinguishes from invasive carcinoma) 3. **Grading dysplasia** — Enables classification as mild, moderate, or severe dysplasia 4. **Prognostic value** — Severe dysplasia and carcinoma in situ carry high risk of progression to invasive cancer ### Why Metaplasia Occurs in Smokers Chronic irritation from cigarette smoke triggers: - Loss of ciliated columnar epithelium (normal respiratory mucosa) - Replacement with stratified squamous epithelium (metaplasia) - Accumulation of genetic mutations (dysplasia) - Potential progression to invasive squamous cell carcinoma **Clinical Pearl:** Squamous metaplasia of the respiratory tract is a reversible change if smoking cessation occurs early. However, once dysplasia develops, the risk of malignant transformation increases significantly. **High-Yield:** The sequence in the respiratory tract is: Normal ciliated epithelium → Squamous metaplasia → Dysplasia (mild → moderate → severe) → Carcinoma in situ → Invasive carcinoma. ### Comparison of Investigations | Investigation | Role | Limitation | |---|---|---| | Bronchial brush biopsy + histology | **Gold standard** — confirms metaplasia and grades dysplasia | Requires bronchoscopy; may miss small lesions | | Sputum cytology | Screening tool; detects malignant cells | Low sensitivity for dysplasia; cannot assess tissue architecture | | CT chest | Assesses mass size, location, staging | Does not differentiate metaplasia from dysplasia or carcinoma | | Immunohistochemistry (p53, Ki-67) | Prognostic markers in established dysplasia/cancer | Not first-line for diagnosis; used after histology confirms dysplasia | **Tip:** Remember that cytology (sputum or brushings without tissue fixation) cannot reliably distinguish metaplasia from dysplasia because architectural relationships are lost. Tissue biopsy is essential. [cite:Robbins 10e Ch 3]